NGM Biopharmaceuticals, Inc.

United States of America (USA)

1 August 2017 - 31 July 2018

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for NGM Biopharmaceuticals, Inc. published between 1 August 2017 - 31 July 2018 which are tracked by the Nature Index.

Hover over the donut graph to view the FC output for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

AC FC
2 1.54

Outputs by subject (FC)

Subject AC FC
Life Sciences 2 1.54

1 August 2017 - 31 July 2018

International vs. domestic collaboration by FC

  • 64.95% Domestic
  • 35.05% International

Note: Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators by FC (2 total)

  • NGM Biopharmaceuticals, Inc., United States of America (USA)
  • Domestic institution
  1. Merck & Co., Inc., United States of America (USA) (0.94)
    0.85
    0.09
  2. Xtal BioStructures, United States of America (USA) (0.91)
    0.85
    0.06

Top 10 international collaborators by FC (1 total)

  • NGM Biopharmaceuticals, Inc., United States of America (USA)
  • Foreign institution
  1. AstraZeneca plc, United Kingdom (UK) (1)
    0.69
    0.31

Note: Collaboration is determined by the fractional count (FC), which is listed in parentheses.

Return to institution outputs